MEREDITH HARKEY: Open Payments
NPI 1770082026 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 23 payments from 11 companies in 2025. Trend: 2023 $1,019 · 2024 $1,056 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $214 |
| AstraZeneca Pharmaceuticals LP | 3 | $144 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Lilly USA, LLC | 2 | $32 |
| ABBVIE INC. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: Wegovy, FARXIGA, REXULTI, AIRSUPRA, Rybelsus, MOUNJARO, VRAYLAR, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
